Cancer clinical trials in the region Nouvelle-Aquitaine
195 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Rectal cancer
Colon cancer
#NCT05253651
Adenocarcinoma
Locally Advanced
Metastatic
HER2
Systemic Treatment-Naive
KRAS G12C
KRAS non G12C
NRAS
Institut Sainte Catherine (Avignon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Centre Hospitalier Universitaire de Besançon (Besançon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain) (and 12 more...)
Seagen
Phase 3
Breast cancer
#NCT04964934
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
Hormone therapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire Dupuytren (Limoges), Groupe Hospitalier Bretagne Sud - Site de Lorient (Lorient) (and 11 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT05552001
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire Dupuytren (Limoges), Gustave Roussy (Villejuif)
Institut Gustave Roussy
Phase 3
Breast cancer
#NCT03878342
HER2 Low
HER2 Negative
HR Positive
Localized
Surgery
Hormone therapy
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Curie - Paris (Paris), Gustave Roussy (Villejuif) (and 25 more...)
UNICANCER
Phase 3
Prostate cancer
#NCT05794906
Adenocarcinoma
Biochemical recurrence
Surgery
Radiotherapy
PSMA PET Positive
Clinique Clémentville (Montpellier), Hôpital Pellegrin (Bordeaux), Hôpital Claude Huriez (Lille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), CHU de Rennes - Hôpital Pontchaillou (Rennes) (and 4 more...)
Bayer
Phase 3
Prostate cancer
#NCT05348577
Adenocarcinoma
Metastatic Castration-resistant
Hormone therapy
Targeted therapy
Hôpital Pellegrin (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital de la Timone AP-HM (Marseille) (and 9 more...)
AstraZeneca
Phase 3
Prostate cancer
#NCT05884398
Adenocarcinoma
Metastatic Hormone-sensitive
Hormone therapy
Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Hôpital Cochin (Paris )
Janssen
Phase 3
Prostate cancer
#NCT04115007
Adenocarcinoma
Metastatic Hormone-sensitive
Institut Sainte Catherine (Avignon), Institut Bergonié (Bordeaux), CHP Brest - Pasteur Vivalto Santé (Brest), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ) (and 26 more...)
UNICANCER
Phase 3
Lung cancer
#NCT05048797
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
HER2
Systemic Treatment-Naive
ALK
EGFR
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Centre hospitalier universitaire François Mitterrand (Dijon), Centre Hospitalier du Mans (Le Mans), Hôpital Nord de Marseille (Marseille Cedex 20) (and 2 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT05078047
HER2 Negative
HR Negative
Metastatic
Immunotherapy
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Henri-Mondor AP-HP (Créteil) (and 16 more...)
UNICANCER